Andere talen Medical & Biological Laboratories Co., Ltd.

Aandelen

4557

JP3131450003

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Crown Bioscience and MBL Enter Joint Venture to Provide Advanced Preclinical Services for Japanese Customers	12-05-22
JSR Corporation acquired remaining 7.27% stake in Medical & Biological Laboratories Co., Ltd. for ¥1.7 billion.	18-12-20
JSR Corporation completed the acquisition of an additional 41.91% stake in Medical & Biological Laboratories Co., Ltd. for ¥9.5 billion.	10-12-20
JSR Corporation made an offer to acquire the remaining 49.2% stake in Medical & Biological Laboratories Co., Ltd. for ¥11.2 billion.	27-10-20
Medical & Biological Laboratories Co., Ltd. Starts the Sale of A Test Kit (For Research Use Only) for Measuring SARS-CoV-2 Neutralizing Antibodies	15-10-20
Medical & Biological Laboratories Co., Ltd. Announces “MEBRIGHTTM SARS-CoV-2 Kit” Was Approved with Marketing Authorization in Japan for the Detection of Novel Coronavirus “SARS-CoV-2”	21-05-20
Medical and Biological Laboratories Co., Ltd. Concludes License Agreement with China National Biotec Group Co., Ltd	11-05-20
Medical & Biological Laboratories Co., Ltd. Launches New ELISA-Based Companion Diagnostic Kit for Spinal Muscular Atrophy	08-05-20
Pmt Corporation Co. Ltd. cancelled the acquisition of Lifetech Co., Ltd from Medical & Biological Laboratories Co., Ltd. and others.	26-09-17
MEDICAL & BIOLOGICAL LABORATORIES Co., Ltd. Enters into Collaboration Agreement with the p53 Laboratory	22-05-17
Pmt Corporation Co. Ltd. agreed to acquire Lifetech Co., Ltd from Medical & Biological Laboratories Co., Ltd. and others for ¥0.07 million.	26-09-16
MBL International Corporation announced that it has received funding from JSR Micro, Inc., Medical & Biological Laboratories Co., Ltd.	21-04-16
MBL International Corporation announced that it expects to receive funding from JSR Micro, Inc., Medical & Biological Laboratories Co., Ltd.	14-03-16
Chiome Bioscience Inc. acquired remaining 47.1% stake in LivTech Inc. from Medical & Biological Laboratories Co., Ltd., KSP Inc., Kouji Nakamura, Hiroyuki Yanai and 3 other individuals.	13-03-15
JSR Corporation completed the acquisition of 13.88% stake in Medical & Biological Laboratories Co., Ltd. for ¥2.2 billion.	11-03-15
JSR Corporation offered a take overbid to acquire 17.9% stake in Medical & Biological Laboratories Co., Ltd. for ¥2.8 billion.	09-02-15
Medical & Biological Laboratories, Co., Ltd. Opens MBL Europe Office in Diegem, Belgium	27-01-15
Medical & Biological Laboratories Co., Ltd. cancelled the acquisition of histopathology examination businesses of Histo Science Laboratory Co., Ltd.	04-07-14
Medical & Biological Laboratories Co., Ltd. cancelled the acquisition of remaining 91.3% stake in ACTGen, Inc. from Toshieki Kajikawa and other shareholders.	22-01-14
Closed Merger/Acquisition Transaction â€“ Target: LivTech Inc.; Buyer(s): Chiome Bioscience Inc.; Seller(s): JAFCO Incubation No. 2 Venture Capital Investment Limited Partnership, KSP Inc., MBL Venture Capital Co., Ltd., Medical & Biological Laboratories Co., Ltd., ReqMed Venture Capital, Yokohama Capital Co. Ltd.; Transaction Size: ¥87.75 mm	25-12-13

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Medical & Biological Laboratories Co., Ltd.

Aandelen

4557

JP3131450003

Andere talen

Filters